TABLE 1.
Fungal and bacterial strains used
| Strain name | Description and Genotype | Reference |
|---|---|---|
| Candida albicans and Candida glabrata | ||
| SC5314-Neon C. albicans | Wildtype clinical isolate, pENO1-NEON-NAT | (82) |
| Caf2-FR C. albicans | SC5314 background; Δura3::imm434/URA3 pENO1-iRFP-NAT | (15) |
| SN250 C. albicans | his1Δ/his1Δ, leu2Δ::C.dubliniensis HIS1/leu2Δ::C.maltosa LEU2, arg4Δ /arg4Δ, URA3/ura3Δ::imm434, IRO1/iro1Δ::imm434 | (83) |
| sef1 Δ/Δ C. albicans | his1Δ/his1Δ, sef1Δ::C.dubliniensis HIS1/sef1Δ::C.maltosa LEU2, arg4Δ/arg4Δ, URA3/ura3Δ::imm434, IRO1/iro1Δ::imm434 | (83) |
| sfu1 Δ/Δ C. albicans | his1Δ/his1Δ, sfu1Δ::C.dubliniensis HIS1/sfu1Δ::C.maltosa LEU2, arg4Δ/arg4Δ, URA3/ura3Δ::imm434, IRO1/iro1Δ::imm434 | (83) |
| NCO-788 C. albicans | Clinical isolate | (84) (Clancy and Shields, U. Pittsburgh) |
| NC1 C. glabrata | Clinical isolate | (84) (Clancy and Shields, U. Pittsburgh) |
| NC999 C. glabrata | Clinical isolate | (84) (Clancy and Shields, U. Pittsburgh) |
| CG-4720 C. glabrata | Clinical isolate | (85) |
| B13-TWO7229#2 C. albicans | Clinical isolate #2 in series from patient. | (84, 86) |
| B14-TWO7230#3 C. albicans | Clinical isolate #3 in series from patient | (84, 86) |
| B15-TWO7241#16 C. albicans | Clinical isolate #16 in series from patient | (84, 86) |
| B16-TWO7243#17 C. albicans | Clinical isolate #17 in series from patient | (84, 86) |
| Pseudomonas aeruginosa | ||
| PA14 dTom | PA14 carrying plasmid encoding dTomato | (80) |
| PA14 ΔlasR | In‐frame deletion of lasR | (87) |
| PA01 WT | Wild type clinical isolate | (88) |
| PAO6382 | PA01 ΔpvdF | (89) |
| PAO6297 | PA01 ΔpchBA | (90) |
| PAO6383 | PA01 ΔpvdFΔpchBA | (90) |
| PA14 WT | Wildtype clinical isolate | (91) |
| PA14 Δphz | In-frame deletion of phzA1-G1 and phzA2-G2 operons, phenazine negative | (91) |
| PA14 phzM::TnM | TnM mutant, 5-MPCA negative | (91) |
| PA14 phzS::TnM | TnM mutant, PYO negative | (91) |